logo

For the Inventor, By the Inventor

Qormi, Malta

Axsome Malta Ltd.


USPTO Granted Patents = 35


Forward Citations = 36

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Katayoun Zomorodi (13 out of 18 patents)

silverMedal Herriot Tabuteau (12 out of 425 patents)

bronzeMedal Moise A Khayrallah (4 out of 16 patents)

4.  Gary Bream (4 out of 16 patents)

5.  Stephen E Butts (4 out of 17 patents)

6.  Clark Patrick Allphin (3 out of 34 patents)

7.  Lawrence Patrick Carter (3 out of 7 patents)

8.  Fionn Hurley (3 out of 8 patents)

9.  Edwin Gerard Walsh (3 out of 7 patents)

10.  Yuan Lu (2 out of 9 patents)

11.  Jennifer Leigh Nelson (25 patents)


Core Competencies:
Solriamfetol Therapy
Obesity Treatment
Carbamoyl Compounds
Lactating Women
Excessive Sleepiness
Phenylpropyl Carbamate
Impaired Renal Function
Cataplexy Treatment

35 patents:

1. 12390419 - Formulations of (R)-2-amino-3-phenylpropyl carbamate (2025-08-19),
2. 12384743 - Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof (2025-08-12),
3. 12318362 - Methods of providing solriamfetol therapy to subjects with impaired renal function (2025-06-03),
4. 12263145 - Methods of administering solriamfetol to lactating women (2025-04-01),
5. 12201601 - Treatment for obesity (2025-01-21),
6. 12194016 - Methods of providing solriamfetol therapy to subjects with impaired renal function (2025-01-14),
7. 12162821 - Treatment of cataplexy (2024-12-10),
8. 12102609 - Methods of administering solriamfetol to lactating women (2024-10-01),
9. 12090126 - Methods of administering solriamfetol to lactating women (2024-09-17),
10. 12064411 - Methods of administering solriamfetol to lactating women (2024-08-20),
11. 12036194 - Methods of administering solriamfetol to lactating women (2024-07-16),
12. 12005036 - Methods of administering solriamfetol to lactating women (2024-06-11),
13. 11998639 - Formulations of (R)-2-amino-3-phenylpropyl carbamate (2024-06-04),
14. 11986455 - Methods of providing solriamfetol therapy to subjects with impaired renal function (2024-05-21),
15. 11986454 - Methods of providing solriamfetol therapy to subjects with impaired renal function (2024-05-21),
Company Overview
Axsome Malta Ltd. is a biotechnology company focused on developing innovative therapies for central nervous system disorders. The organization specializes in the research and development of novel pharmacological solutions aimed at addressing unmet medical needs in areas such as pain management, depression, and neurodegenerative diseases. With a commitment to advancing healthcare, Axsome leverages cutting-edge science and technology to enhance patient outcomes and improve quality of life. The company operates within the dynamic landscape of the biotech industry, contributing to advancements in therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

35 Patents

#1 in Qormi

#4 in Malta

#19,168 in the World

Qormi, MT
Qormi, Malta

Axsome Malta Ltd.

Forward Citations = 36

10 inventors:

goldMedal Katayoun Zomorodi (13 out of 18 patents)

silverMedal Herriot Tabuteau (12 out of 425 patents)

bronzeMedal Moise A Khayrallah (4 out of 16 patents)

4.  Gary Bream (4 out of 16 patents)

5.  Stephen E Butts (4 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Axsome Malta Ltd.. Retrieved from https://idiyas.com/company/axsome-malta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…